End-Stage Liver Disease
16
2
2
8
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
12.5%
2 terminated out of 16 trials
80.0%
-6.6% vs benchmark
6%
1 trials in Phase 3/4
13%
1 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 8 completed trials
Clinical Trials (16)
Physical and Cognitive Outcomes After Post-Transplant Physiotherapy in Liver Transplant Recipients
Nutrition and Exercise Prehabilitation in Patients Awaiting Liver Transplantation
Effect of Different Frequencies of Umbilical Cord-mesenchymal Stem Cells Through Peripheral Vein in Patients With ESLD
Multidimensional Frailty Assessment and Post-Transplant Outcomes in Liver Transplant Candidates
Surprise Question in End of Life (SeQuEL) Care and the Effect of Prompting Palliative Care Consultation: End-Stage Liver Disease
Goals of Care Conversations Study
Effects of Aerobic and Resistance Exercises on Inpatients Liver Transplantation Recipients
Liver Transplantation With Two-stage Liver Resection in Unresectable Liver Cancer , Metastases or Emd-stage Liver Disease (LTLR-LC)
Using Ex-vivo Normothermic Machine Perfusion With the Organox Metra™ Device to Store Human Livers for Transplantation
Supplements SMOF in TPN for Liver Transplantation Recipients
Trial of Calcineurin Inhibitor-Sparing Immunosuppression Regimen in Pediatric Liver Transplantation
Safety and Efficacy Study of Regulatory T Cell Therapy in Liver Transplant Patients
A2ALL-Patients Safety System Improvements in Living Donor Liver Transplantation
Evaluation of the Safety of Octaplas™ Versus Plasma in Patients Undergoing Orthotopic Liver Transplantation
Conditioning With Volatile Anesthetics in Liver Transplantation
Prospective Trial Comparing Conventional Versus Piggyback Method in Venous Drainage of the Transplanted Liver